| scholarly article | Q13442814 |
| P50 | author | Steven G Deeks | Q57425986 |
| P2093 | author name string | David Favre | |
| Joseph M McCune | |||
| Douglas F Nixon | |||
| Elizabeth Sinclair | |||
| Jeffrey N Martin | |||
| Priscilla Hsue | |||
| Brinda Emu | |||
| Rebecca Hoh | |||
| Walter J Moretto | |||
| P2860 | cites work | Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 |
| Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection | Q24795912 | ||
| Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene | Q28593669 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype | Q33604661 | ||
| Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation | Q33809451 | ||
| In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients | Q33840429 | ||
| Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection | Q33869806 | ||
| The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. | Q33971012 | ||
| IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation | Q33977594 | ||
| HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course | Q79347477 | ||
| T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy | Q34193786 | ||
| Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells | Q34289467 | ||
| Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity | Q34976619 | ||
| T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis | Q35543827 | ||
| Treatment of antiretroviral-drug-resistant HIV-1 infection | Q35610798 | ||
| HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function | Q35834664 | ||
| Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know | Q35852348 | ||
| Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition | Q35876884 | ||
| Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics | Q36364647 | ||
| HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity | Q36371562 | ||
| Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children | Q36404594 | ||
| Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 | Q36474240 | ||
| Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals | Q36602397 | ||
| Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression | Q39602846 | ||
| The prevalence of antiretroviral drug resistance in the United States | Q39687529 | ||
| Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs | Q41018351 | ||
| The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses | Q41870329 | ||
| HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression | Q43750477 | ||
| Studies in subjects with long-term nonprogressive human immunodeficiency virus infection | Q44369963 | ||
| Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions | Q44443175 | ||
| Use of overlapping peptide mixtures as antigens for cytokine flow cytometry | Q45112956 | ||
| Skewed maturation of memory HIV-specific CD8 T lymphocytes | Q45284555 | ||
| Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. | Q45699170 | ||
| Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy | Q45721932 | ||
| Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections | Q45733084 | ||
| Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors | Q45747345 | ||
| Quantitation of CD38 expression using QuantiBRITE beads | Q46490538 | ||
| Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. | Q51995303 | ||
| Immune control of HIV-1 after early treatment of acute infection | Q56961920 | ||
| HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication | Q61941182 | ||
| Seventeen-colour flow cytometry: unravelling the immune system | Q62577376 | ||
| Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression | Q71803154 | ||
| Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta | Q72287439 | ||
| Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
| CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 | Q74660381 | ||
| HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors | Q78342521 | ||
| Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection | Q78551235 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 14169-14178 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment | |
| P478 | volume | 79 |
| Q33815728 | A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers |
| Q34743336 | A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response |
| Q33715758 | Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats |
| Q37788680 | Altered Host-Microbe Interaction in HIV: A Target for Intervention with Pro- and Prebiotics |
| Q61446023 | An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers |
| Q93196555 | Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination |
| Q36099280 | Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol |
| Q37171529 | Bayesian semiparametric mixture Tobit models with left censoring, skewness, and covariate measurement errors |
| Q34428561 | Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides |
| Q92826937 | CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome |
| Q35216907 | CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors |
| Q38098176 | Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. |
| Q84295171 | Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation |
| Q34142433 | Changes in function of HIV-specific T-cell responses with increasing time from infection |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q34335751 | Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage |
| Q36833017 | Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature |
| Q42076273 | Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. |
| Q34083315 | Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers |
| Q40299563 | Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice. |
| Q33805995 | Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers |
| Q47600979 | Cost-Effectiveness of Peer- Versus Venue-Based Approaches for Detecting Undiagnosed HIV Among Heterosexuals in High-Risk New York City Neighborhoods. |
| Q40385320 | Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression |
| Q36845698 | DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles |
| Q37628515 | Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine |
| Q61807015 | Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4 T Cells to the Dengue Virus Envelope Protein Domain III |
| Q34427822 | Development of skewed functionality of HIV-1-specific cytotoxic CD8(+) T cells from primary to early chronic phase of HIV infection |
| Q35826902 | Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers |
| Q36930427 | Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections |
| Q34883548 | Differential microRNA regulation of HLA-C expression and its association with HIV control |
| Q37077305 | Disease Progression in HIV-1-Infected Viremic Controllers |
| Q38086435 | Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it? |
| Q37344826 | Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load |
| Q92884412 | Effect of HIV infection and antiretroviral therapy on immune cellular functions |
| Q35678576 | Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection |
| Q41359297 | Effective downregulation of HLA-A*2 and HLA-B*57 by primary human immunodeficiency virus type 1 isolates cultured from elite suppressors |
| Q35001377 | Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? |
| Q35586299 | Elevated caspase-3 expression and T-cell activation in elite suppressors |
| Q56994404 | Elite control of HIV infection: implications for vaccine design |
| Q36086732 | Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses |
| Q36498230 | Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy |
| Q37033224 | Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy |
| Q35692024 | Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity |
| Q33723141 | Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda |
| Q36529008 | Functional signatures of protective antiviral T-cell immunity in human virus infections. |
| Q34009945 | Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. |
| Q36845893 | Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes |
| Q37409439 | Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease |
| Q41546145 | Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre-and post- HAART show immune activation and inflammation the main drivers of host gene expression |
| Q46042029 | HIV and Age Do Not Synergistically Affect Age-Related T cell Markers |
| Q33535905 | HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity |
| Q41762711 | HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. |
| Q34190681 | HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses |
| Q38114915 | HIV controllers: a genetically determined or inducible phenotype? |
| Q37921949 | HIV controllers: a multifactorial phenotype of spontaneous viral suppression |
| Q34707327 | HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells |
| Q36849780 | HIV vaccines: can CD4+ T cells be of help? |
| Q34275430 | HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses |
| Q34699130 | HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers |
| Q90446339 | HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India |
| Q26799624 | HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies |
| Q38610690 | HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control |
| Q33918894 | HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. |
| Q33406497 | High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication |
| Q41189354 | High immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected Chinese rhesus macaques |
| Q36926499 | Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women |
| Q37807749 | Human cytomegalovirus immunity and immune evasion |
| Q36315044 | Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines |
| Q33952015 | Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy |
| Q40739042 | Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers |
| Q28478654 | Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection |
| Q34292622 | Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients |
| Q45399547 | Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy |
| Q30362489 | Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? |
| Q34033051 | Immunity to HIV in Early Life |
| Q34120763 | Immunodominant HIV-Specific CD8+T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers |
| Q37051202 | Immunogenetics of spontaneous control of HIV |
| Q43608840 | Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control |
| Q35683067 | Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study. |
| Q40800858 | Immunologic profiles distinguish aviremic HIV-infected adults |
| Q33779043 | Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection |
| Q30494738 | Improving defences at the portal of HIV entry: mucosal and innate immunity |
| Q30372415 | Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. |
| Q37200459 | Influence of HLA-C expression level on HIV control |
| Q37944321 | Innate immune recognition of poxviral vaccine vectors |
| Q34056087 | Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. |
| Q52692807 | Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. |
| Q38086432 | Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses |
| Q39776645 | Loss of T cell responses following long-term cryopreservation |
| Q37054526 | Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control |
| Q43036651 | MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. |
| Q40695938 | Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens |
| Q33828507 | Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers |
| Q22251054 | Microbial translocation is a cause of systemic immune activation in chronic HIV infection |
| Q35857703 | Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. |
| Q34206267 | Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. |
| Q40120996 | Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status |
| Q34651668 | Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses |
| Q34274849 | New approaches to design HIV-1 T-cell vaccines |
| Q37255619 | Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice |
| Q49124572 | Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. |
| Q36618086 | Polyfunctional T cell responses are a hallmark of HIV-2 infection |
| Q36845770 | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. |
| Q36315197 | Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study |
| Q35018065 | Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers |
| Q39219360 | Psoriasis risk SNPs and their association with HIV-1 control |
| Q64374806 | Quantitative and Qualitative CD4 T Cell Immune Responses Related to Adenovirus DNAemia in Hematopoietic Stem Cell Transplantation |
| Q104461553 | Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases |
| Q34269570 | Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. |
| Q36304297 | Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy |
| Q36759963 | Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model. |
| Q37215251 | Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis |
| Q36462335 | SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment |
| Q35752812 | Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection |
| Q38491191 | Success and failure of the cellular immune response against HIV-1. |
| Q36229046 | Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression |
| Q35216404 | T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus |
| Q37062264 | The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. |
| Q34763599 | The human fetal immune response to hepatitis C virus exposure in utero |
| Q36979967 | Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection |
| Q64062767 | Transcriptional down-regulation of in a subset of HIV+ controllers and their family members |
| Q35023986 | Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection |
Search more.